Authors: Haas, DW Fessel, WJ Delapenha, RA Kessler, H Seekins, D Kaplan, M Ruiz, NM Ploughman, LM Labriola, DF Manion, DJ

Citation: Dw. Haas et al., Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: A randomized, double-blind, placebo-controlled trial, J INFEC DIS, 183(3), 2001, pp. 392-400

Authors: Falloon, J Piscitelli, S Vogel, S Sadler, B Mitsuya, H Kavlick, MF Yoshimura, K Rogers, M LaFon, S Manion, DJ Lane, HC Masur, H

Citation: J. Falloon et al., Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity, CLIN INF D, 30(2), 2000, pp. 313-318

Authors: Manion, DJ Ruiz, NM Staszewski, S

Citation: Dj. Manion et al., Efavirenz in HIV infection. Reply, N ENG J MED, 342(17), 2000, pp. 1290-1291

Authors: Staszewski, S Morales-Ramirez, J Tashima, KT Rachlis, A Skiest, D Stanford, J Stryker, R Johnson, P Labriola, DF Farina, D Manion, DJ Ruiz, NM

Citation: S. Staszewski et al., Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults, N ENG J MED, 341(25), 1999, pp. 1865-1873